All authors: Department of Medicine, University of Chicago, Chicago, IL.
Crit Care Med. 2018 Jul;46(7):1070-1077. doi: 10.1097/CCM.0000000000003123.
To develop an acute kidney injury risk prediction model using electronic health record data for longitudinal use in hospitalized patients.
Observational cohort study.
Tertiary, urban, academic medical center from November 2008 to January 2016.
All adult inpatients without pre-existing renal failure at admission, defined as first serum creatinine greater than or equal to 3.0 mg/dL, International Classification of Diseases, 9th Edition, code for chronic kidney disease stage 4 or higher or having received renal replacement therapy within 48 hours of first serum creatinine measurement.
None.
Demographics, vital signs, diagnostics, and interventions were used in a Gradient Boosting Machine algorithm to predict serum creatinine-based Kidney Disease Improving Global Outcomes stage 2 acute kidney injury, with 60% of the data used for derivation and 40% for validation. Area under the receiver operator characteristic curve (AUC) was calculated in the validation cohort, and subgroup analyses were conducted across admission serum creatinine, acute kidney injury severity, and hospital location. Among the 121,158 included patients, 17,482 (14.4%) developed any Kidney Disease Improving Global Outcomes acute kidney injury, with 4,251 (3.5%) developing stage 2. The AUC (95% CI) was 0.90 (0.90-0.90) for predicting stage 2 acute kidney injury within 24 hours and 0.87 (0.87-0.87) within 48 hours. The AUC was 0.96 (0.96-0.96) for receipt of renal replacement therapy (n = 821) in the next 48 hours. Accuracy was similar across hospital settings (ICU, wards, and emergency department) and admitting serum creatinine groupings. At a probability threshold of greater than or equal to 0.022, the algorithm had a sensitivity of 84% and a specificity of 85% for stage 2 acute kidney injury and predicted the development of stage 2 a median of 41 hours (interquartile range, 12-141 hr) prior to the development of stage 2 acute kidney injury.
Readily available electronic health record data can be used to predict impending acute kidney injury prior to changes in serum creatinine with excellent accuracy across different patient locations and admission serum creatinine. Real-time use of this model would allow early interventions for those at high risk of acute kidney injury.
利用电子病历数据开发急性肾损伤风险预测模型,以便在住院患者中进行纵向使用。
观察性队列研究。
2008 年 11 月至 2016 年 1 月期间,三级城市学术医疗中心。
所有入院时无预先存在的肾功能衰竭的成年患者,定义为首次血清肌酐值大于或等于 3.0mg/dL,国际疾病分类第 9 版,慢性肾脏病 4 期或更高期别的编码,或在首次测量血清肌酐后 48 小时内接受肾脏替代治疗。
无。
使用梯度提升机算法将人口统计学、生命体征、诊断和干预措施用于预测基于血清肌酐的肾脏病改善全球结局的 2 期急性肾损伤,其中 60%的数据用于推导,40%用于验证。在验证队列中计算了接收器操作特征曲线下面积(AUC),并进行了亚组分析,涉及入院时的血清肌酐、急性肾损伤严重程度和医院位置。在 121158 例纳入患者中,17482 例(14.4%)发生任何肾脏病改善全球结局的急性肾损伤,其中 4251 例(3.5%)发生 2 期。24 小时内预测 2 期急性肾损伤的 AUC(95%CI)为 0.90(0.90-0.90),48 小时内为 0.87(0.87-0.87)。在接下来的 48 小时内接受肾脏替代治疗(n=821)的 AUC 为 0.96(0.96-0.96)。在不同的医院环境(ICU、病房和急诊室)和入院时的血清肌酐分组中,AUC 相似。在概率阈值大于或等于 0.022 时,该算法对 2 期急性肾损伤的敏感性为 84%,特异性为 85%,预测 2 期急性肾损伤的中位数为 41 小时(四分位距,12-141 小时),早于 2 期急性肾损伤的发生。
可利用电子病历数据在血清肌酐发生变化之前预测即将发生的急性肾损伤,在不同的患者位置和入院时的血清肌酐分组中具有极好的准确性。实时使用该模型可使高危急性肾损伤患者早期干预。